ALI MELHEM: Open Payments
NPI 1285788430 · BELLAIRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$123,393 in 109 payments from 6 companies in 2025. Trend: 2023 $139,827 · 2024 $103,055 · 2025 $123,393
Speaker / faculty: $87,890Travel & lodging: $24,298Consulting: $8,998Food & beverage: $2,208
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 75 | $92,125 |
| E.R. Squibb & Sons, L.L.C. | 24 | $30,842 |
| Axsome Therapeutics, Inc. | 2 | $177 |
| Alkermes, Inc. | 4 | $153 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
Products named: VRAYLAR, COBENFY, Auvelity, LYBALVI, HETLIOZ, INGREZZA.
Industry payments across OH — which companies pay providers there.
